Hamburg, Germany, 07 March 2019:

Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at and attending the following upcoming conferences:

BioCapital Europe, Amsterdam, The Netherlands

Date: Thursday, 14 March 2019, Presentation: 14 March 2019, 11.20 am CET (6.20 am EDT, 10.20 am GMT)

Venue: Amsterdam, The Netherlands

Attendee: Enno Spillner, Chief Financial Officer

Bankhaus Lampe Deutschlandkonferenz, Baden-Baden, Germany

Date: Friday, 05 April 2019

Venue: Baden-Baden, Germany

Attendee: Enno Spillner, Chief Financial Officer

H.C. Wainwright Global Life Sciences Conference, London, UK

Date: Monday, 08 April 2019

Venue: London, UK

Attendee: Enno Spillner, Chief Financial Officer

Kempen & Co Life Sciences Conference, Amsterdam, The Netherlands

Date: Tuesday, 17 April 2019

Venue: Amsterdam, The Netherlands

Attendee: Dr Werner Lanthaler, Chief Executive Officer

FORWARD LOOKING STATEMENTS 

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.